Oxidative DNA Damage by N(4)-hydroxycytidine, a Metabolite of the SARS-CoV-2 Antiviral Molnupiravir

Molnupiravir is an antiviral agent recently used for treating coronavirus disease 2019 (COVID-19). Here, we demonstrate that N(4)-hydroxycytidine (NHC), a molnupiravir metabolite, treated with cytidine deaminase (CDA) induced Cu(II)-mediated oxidative DNA damage in isolated DNA. A colorimetric assay...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Hatasu, Mori, Yurie, Ahmed, Sharif, Hirao, Yuichiro, Kato, Shinya, Kawanishi, Shosuke, Murata, Mariko, Oikawa, Shinji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132762/
https://www.ncbi.nlm.nih.gov/pubmed/36461940
http://dx.doi.org/10.1093/infdis/jiac477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132762/
https://www.ncbi.nlm.nih.gov/pubmed/36461940
http://dx.doi.org/10.1093/infdis/jiac477

Ejemplares similares